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Abstract Objective Adherence to medication in patients
with type 2 diabetes varies widely, yet the factors that
influence adherence according to patients are not fully
known. The aim of this study is to explore both factors
related to high and lower levels of adherence that patients
with type 2 diabetes experienced in their medication use.
Setting Primary care in the Netherlands. Method Qualita-
tive, semi-structured interviews were performed in 20
patients with type 2 diabetes. Interviews were audio-taped
and transcribed verbatim. Transcripts were coded and
analysed using content analysis and constant comparison.
Main outcome measure experiences and opinions of
patients concerning factors related to high and lower levels
of adherence. Results Comparable aspects influenced drug
adherence in more and less adherent patients. Four aspects
that influenced adherence to medication emerged from the
interviews: (1) information about the prescribed medica-
tion, (2) experience with medication and complications
with use, (3) social support for medication behaviour and
(4) routines in medication behaviour. Experience with
medication and social support for medication behaviour
were related to high levels of adherence in some patients,
and to lower levels of adherence in others. Complicated
medication regimens were mainly related to lower adher-
ence, while social support and routines in medication
behaviour were related to higher adherence. Conclusions
Routines in medication behaviour were related to higher
drug adherence. Patient education should not only address
information about the disease and medication, but also
more practical issues concerning drug intake. Hence, to
improve drug adherence in patients with type 2 diabetes,
pharmaceutical care might be aimed at the counselling of
patients to organise drug use in their daily schedule.
Keywords Adherence  Drug use  Netherlands  Patient
education  Primary care  Qualitative research  Type 2
diabetes
Impact of findings on practice
• Practical information about how to fit drugs in daily
routines could support patients in their adherence to
medication.
• Factors such as information about medication and
individual experiences with medication can be related
to high as well as low adherence, hence interventions to
improve adherence should be tailored to the individual
patient.
• Positive and negative experiences of patients and his/
her relatives with medication can influence adherence
to medication. Exploration of these experiences in
counselling can give useful information to support
adherence.
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Introduction
Adherence rates to drug regimens in patients with type 2
diabetes are relatively low, and vary widely between
populations with adherence rates between 36 and 94% [1–
3]. Health care providers can motivate patients to be
adherent, but the diabetes care has to be performed by the
patient himself. Health care professionals have little direct
control how patients manage their illness [4]. However,
results of studies show growing evidence that patient out-
comes are improved by changes in the process of care or by
counselling the patient. To develop effective interventions
and to train health care professionals to support patients, it
is important to know which factors influence adherence
with drug treatment [5].
Epidemiological studies have found many factors asso-
ciated with drug adherence [6–9]. Reviews report that
adherence has been associated with patient factors, social
and medical support, and medication related aspects [1,
10]. Patient factors are for example the patient’s age (older
patients being more adherent), economic status (patients
with a higher economic status being more adherent) and
health beliefs (patients with beliefs about medicines as
something harmful were less adherent) [1, 6, 11–13].
Social and medical support include among others family
help and the patient-health care provider relationship, and
patients with more support were more adherent. Medica-
tion related factors take into account the attitude towards
medicines, the complexity of the medication regimen and
the experience of side effects [8, 9, 11]. A positive attitude
towards medicines, a less complex medication regimen and
less experience of side effects were related to higher
adherence rates. Studies that focussed on the patient’s
perspective and his experiences with drug adherence have
been performed less frequently [14, 15].
Qualitative studies explored aspects that influenced the
patient’s opinion on several aspects of diabetes management
[16–18]. These studies found that health beliefs, quality of
the doctor/patient relationship, the course of diabetes and
quality of information influenced drug adherence. Examples
of these findings are that health beliefs could lead to reduced
adherence due to lack of understanding of diabetes and its
treatment. Also, health beliefs of patients could lead to adapt
the recommended treatment and hence reduce adherence.
Within the doctor/patient relationship patients perceived the
doctor blaming the patient for negative health outcomes, and
physicians not understanding the patient’s difficulties as
obstacles to adherence. With respect to information, lack of
knowledge and conflicting information about the treatment
could influence adherence negatively.
In order to develop interventions that improve diabetes
care, the patient’s perspective needs to be investigated
further.
Aim of the study
The aim of the study was to explore both factors related to
high and lower levels of adherence that patients experi-
enced in their medication use, and to reflect upon the
findings in the context of patient education and shared
decision making.
Method
Study design
Qualitative, semi-structured interviews in patients with
type 2 diabetes in primary care in the Netherlands.
Patient selection
Source population: patients were approached within the
context of an educational epidemiological survey by health
science students of the VU University Amsterdam. Fifty-
four family practices participated, and 60 students
approached up to five patients in one practice. A total of
254 patients agreed to participate in a questionnaire study
designed to study adherence among patients with type 2
diabetes [19]. Patients were from all over the Netherlands
and were prescribed at least one oral anti-diabetic drug,
were older than 40 years and their GP was (one of) the
primary caregiver(s). All patients had adequate command
of the Dutch language. The 173 (68%) patients who were
willing to participate in future research, were the source
population for this qualitative study.
In the survey, adherence for each drug that was used was
measured with the Medication Adherence Rating Scale
(MARS-5) [20, 21]. The MARS is a questionnaire with five
questions with for each question answer categories ranging
from 1 (least adherent) to 5 (most adherent), so the higher
scores suggest better adherence.
Study population: to include opinions of both adherent
and less adherent patients, a theoretical sampling strategy
was used [22]. Previous studies using the MARS-score to
differentiate in high and lower adherence used different
cut-off points [8, 23, 24]. As adherent patients we included
10 people with a maximum score of 25 on all drugs they
used. As less adherent patients we approached the patients
with the lowest MARS-score in our sample. These patients
scored on at least one of their drugs a total MARS score
below 21, and a score of 3 or less on at least two questions.
We approached an equal number of adherent and less
adherent patients to participate. Within this sample, we
aimed to include a similar proportion of male and female
patients, and patients from different age. Prior to the
interview, each patient was contacted by phone: the
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investigators briefly described the aim of the patient
interview, and sent an information sheet to the potential
participant. The investigators (IK and JM) then made an
appointment with the patient for the interview. Before the
interview started the patients gave informed consent.
Interviews: semi-structured, in-depth interviews were
performed in the patients’ home. Patients were interviewed
about their experiences with all drugs that were used and
the factors related to high and lower levels of adherence
they experienced. During the interview no reassessment of
adherence with the MARS-questionnaire was performed.
The interviews took 40–90 min and during the first four
interviews we evaluated whether the topics in our guide
were adequate to answer the research questions. In each
interview open questions were formulated that covered
general areas of interest as listed in the final topic guide
(see Table 1). During the interviews, patients were asked to
elaborate about these topics and to mention all subjects
relevant from their own points of view. Partners or family
members were not invited to participate, but if a partner of
family member was present during an interview, their
comments were welcomed and included in the data. The
researchers assured that the information would remain
confidential and that confidentiality was considered to their
health care providers. All interviews were audio-taped,
transcribed verbatim, and rendered anonymously. The
investigators read the transcript while listening to an
interview to ensure textual accuracy. The transcripts of the
interviews then served as data.
The interviews were performed by two health sciences
students (IK and JM). Prior to the interviews, both had
followed an interview training, and during the entire
interview period they were supervised by experienced
qualitative researchers (SB and MW).
Analysis
Background characteristics concerning age, gender, the
number of medicines the patient used and how long they
had been diagnosed with diabetes were derived from the
database. The mean number of antidiabetic drugs per
patient was calculated. Concomitant medication was clas-
sified according to ATC-codes [25]: cardiovascular medi-
cation (ATC-code C) was classified in cholesterol lowering
drugs (ATC C10), and other cardiovascular drugs. Medi-
cation used for pain consisted of the combined classes M01
and N01. The number of patients with at least one drug in
the six most frequently used ATC-classes other than anti-
diabetic drugs was presented. Also the mean number of
drugs used by the patients within classes was calculated.
All other drugs were categorized as ‘other’.
All interview transcripts were analysed with support of
QSR Nvivo 2.0, an established software package for
ordering qualitative data. The first four interviews were
transcribed and analysed directly after the interview to
confirm the validity of the topic list. At the time ten
interviews were carried out, certain themes began to be
repeated (data saturation). The investigators coded these
first ten transcripts independently to identify key themes,
using the themes from the topic list (see Table 1) and
themes that they considered to be important as codes.
Citations from patients and partners covering these topics
were included in the analysis. In the subsequent interviews
these themes were further developed until additional
interviews provided no new information with respect to the
research question. During analysis, the authors ensured
validity of the results by critical discussion and searching
for cases which seemed to verify or to conflict with the
insights derived from the interim analysis.
Ethical Approval: this study was exempt from review by
the Medical Ethics Committee of the VU University
Medical Center, as Dutch legislation does not request this
for studies that do not affect the patient’s integrity.
Results
Patient characteristics
Between April and June 2006, 22 patients were approached
by the researchers. A total of 20 patients was included in
the study. In three of the interviews, a partner (spouse)
contributed to the interview, and their comments added
information about the patient’s thoughts and experiences.
Table 2 summarizes the characteristics of the patients. Half
Table 1 Topics of the interview
How do patients use/organise their medication
Experiences with not taking medication
Reasons for non-adherence
Factors related to high levels of adherence for medication
Factors related to lower levels of adherence for medication
Checklist for possible factors related to high or lower levels of
adherence for medicationa
Forgetting
Social environment
Effect of medication
Side effects of medication
Information and knowledge about medication
Relation with general practitioner
Complexity of drug regimen
a After the first four interviews we noticed that patients found it
difficult to describe factors related to high and lower levels of
adherence spontaneously. After the open questions, we added a
checklist that was used to trigger them to elaborate on possible factors
related to adherence
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of the patients had a maximum MARS-score for adherence
(adherent), and half of the patients scored three or lower on
at least two of the five questions (less adherent). The mean
age of the more and less adherent patients was comparable,
and male and female patients were equally represented in
both groups. Patients used comparable medication for
concomitant diseases: most patients used cardiovascular
medication to control blood pressure, and cholesterol
lowering drugs (Table 3). Other frequently used drugs in
both groups were drugs for other chronic diseases: ali-
mentary tract/metabolism, blood and blood forming organs
(anti-coagulants), analgesics and respiratory drugs.
Aspects emerging from the analysis
Four aspects that influenced adherence to medication
emerged from the interviews: (1) information about the
prescribed medication, (2) experience with medication and
complications with using medication, (3) support for med-
ication behaviour and (4) routines in medication behaviour.
Information, experience with medication, and support for
medication behaviour were related to high adherence in
some patients, while the same aspects were related to lower
adherence in others. If patients experienced their medica-
tion complicated to use, this was related to lower levels of
adherence. Routines in medication behaviour were associ-
ated with high adherence. The factors related to high and
lower levels of adherence were expressed by adherent as
well as less adherent patients, and we found no indication
for differences between male and female patients nor dif-
ferent factors raised by younger and elderly patients. Most
patients found it difficult to describe factors related to high
and lower levels of adherence spontaneously, however they
were triggered by the items we used on the checklist. The
citations shown exemplify the opinions of the patients.
Information about the medication
Information and knowledge about medication emerged as
one of the aspects related to adherence in both more and
less adherent patients, however we did not measure
knowledge with a questionnaire. When patients spoke
about information they sometimes spoke about (lack of)
knowledge as the possible result of having (in)sufficient
information. Patients distinguished different sources of
information about medication. Verbal instructions by the
prescriber were mentioned, and also written and oral
information by the pharmacy, and the package leaflet of the
specific drug. This is illustrated by the following patients
who summarized some of these sources:
Table 2 Characteristics of the interviewees (n = 20)
Adherenta Less
adherentb
Gender
Male 5 5
Female 5 5
Age, mean (range) 68 (52–85) 72 (62–92)
Number of years diagnosed with diabetes
(range)
6.0 (2–16) 4.5 (1–10)
Total 10 10
a Adherent patients were defined as patients with a maximum MARS-
score of 25 for all drugs they used
b Less adherent patients were defined as patients who scored B3 on at
least 2 of the 5 questions of the MARS-questionnaire for at least one
of the drugs they used
Table 3 Drugs used by the interviewees (n = 20)
Adherenta Less adherentb
ATC-class of drugs (ATC) Patients
(n)
Drugs per patientc (mean,
range)
Patients
(n)
Drugs per patientc (mean,
range)
Antidiabetic drugs (ATC = A10) 10 1.6 (1–2) 10 1.3 (1–2)
Alimentary tract and metabolism (ATC = A, without
antidiabetic drugs)
5 1 (1) 6 1.2 (1–2)
Blood and blood forming organs (ATC B) 4 1.3 (1–2) 3 2 (1–3)
Cholesterol lowering drugs (ATC = C10) 7 1 (1) 5 1 (1)
Cardiovascular system (ATC = C, all other) 9 2.7 (1–5) 7 1.9 (1–3)
Analgesics (ATC = M01, N01) 2 1 (1) 3 2 (1–3)
Respiratory system (ATC = R) 2 1 (1) 3 3 (1)
Other 5 1.8 (1–3) 7 1.9 (1–4)
Total 10 7.0 (4–10) 10 6.6 (4–10)
a Adherent patients were defined as patients with a maximum MARS-score of 25 for all drugs they used
b Less adherent patients were defined as patients who scored B3 on at least 2 of the 5 questions of the MARS-questionnaire for at least one of the
drugs they used
c Mean number of drugs per patient that used at least one drug within this category
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‘‘Well, it [knowledge about medicines] is important
as it concerns the doctor’s advice how to take med-
icines. You follow his advice… and you read the
package leaflet. The pharmacy provides those big
information sheets, with everything written clearly.
Well you read everything…’’ (Woman, 62 years, less
adherent)
Knowledge about medication was for many patients rather
limited, however lack of information was not always
considered a limiting factor for adherence by the patients
themselves:
Knowledge about medication? I have no idea! I
Medicines are prescribed, I use them. That’s it. I
never read the package leaflet. When you read it, you
lose courage to use them any longer, and in my
opinion you have to use them… the colours tell me
how: blue is for the prostate, and I have orange and
white, and for my sugar I use a tablet somewhat
larger. I also have another one for my stomach. (male,
71 years, less adherent)
For some patients however, information about the medi-
cation and the underlying disease was important and
associated with the intention to comply to their medication
regimen:
It [my diabetes related medication] has been
explained very well. This disease may damage your
veins, your eyes, and even more. It will destroy you:
that was explained perfectly. For me it was clear,
hence I use my medicines and understand their
importance. (male, 52 years, adherent)
Experience with medication and complications
with usage
Patients’ experiences with medicines influenced their atti-
tude and this was related to their level of adherence. Direct
influences were the effects that patients experienced when
they omitted medication, such as pain or heart burn. To
prevent these reactions they complied to their regimen.
When patients experienced side effects, some patients
stopped their medication:
If I experience side effects, l stop taking medicines. I
don’t feel well. And then, my doctor thinks: what to
do next? Usually he prescribes me another drug.
(female, 72 years, adherent)
Not only current, but patients’ past experiences with health
care affected their adherence. Moreover, experiences of
close friends and family members with medication could
lead to beliefs in the necessity of treatment that influenced
drug adherence. An example was a patient who was
motivated to comply with her medication regimen because
she had seen the complications of diabetes in her family:
I had a sister in law, she died recently. It started with
losing a toe, then the top of her foot, later her leg till
under her knee, and finally she lost her whole leg.
Well, now she does not live any more. That frightens
me very much. (female, 65, adherent)
For most patients, using medication in daily practice was
complicated. Patients distinguished two aspects: complex-
ity because they had to take medication at different times a
day, and complexity in taking the right amount of
medication because they had to take more than one drug,
or had to perform difficult actions before they could take
the drug. Another aspect of the complexity of taking
medicines at different times was that this was (more)
difficult to schedule. This was problematic for a patient
who had to combine oral anti-diabetics with insulin:
A tablet is easier to take, it doesn’t matter when you
take it half an hour earlier or later. But when you
inject insulin, it has to be at the right time. You must
inject and eat directly. (woman, 65, adherent)
Taking the right amount was sometimes complex when
patients had to split the tablets themselves, because they
had to take another amount than one (whole) tablet.
When you split them [the tablets]—and that is
strange—1 day you have three quarters of a tablet
and the other day you only have one quarter. You
have to cut them on the line of fracture. And I have to
use them, you can’t throw it away! (male, 72 years,
adherent)
Many patients had experienced a situation in which it was
difficult to take all the medication, because of the quantity
or because of size. Only in one case it was mentioned this
was actually a factor that limited adherence:
Well he [my husband] says: ‘‘that one I won’t take
today. That’s such a big one, he will stuck in my
throat, and then my throat will be burning.’’ (partner
of patient, 71 years, female, less adherent)
Social support for medication behaviour
We used Dalgard’s conceptualization of social support as
‘help in difficult life situations’ [26]. Patients experienced
support for their medication behaviour by both their social
environment and health care professionals. Most patients
trusted their treating physician(s), although this was not
always related to improved adherence of these patients.
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The next thoughts are from a patient who trusted his
physician, and who did not discuss his medication with his
physician:
‘‘My point of view is that these people (physicians)
have studied, and have proven they can do something
in our society. You surrender to them. When he
prescribes, who am I to ask: ‘does that drug do
anything?’ In the end, I am a layman.’’ (male,
76 years, less adherent)
However, not every patient had such an opinion of his/her
physician, in one extreme case a patient experienced lack
of support and this resulted in an repulsive attitude of the
patient to her physician:
Well, my GP and I, we don’t like each other. We
have had a conflict several times. He can say to me
‘‘you should do this or that’’, but I will not listen to
him! (female, 71 years, less adherent)
Most patients considered their medication their individual
responsibility, and help of their partner or children was not
needed. For them, support from their social environment
was not an issue. Others needed help for practical reasons
such as a bad visibility or not being able to get tablets out
of the blisters. Also, six patients (five of them males)
appreciated help by partners or children, sometimes
indolence was the main reason:
Well, I can manage it myself [my medication], but it
is very easy when she [his wife] thinks about it!
(male, 67 years, adherent)
Routines in medication behaviour
Many factors that influenced adherence had to do with the
daily routine of taking medication. Disturbances in this
routine were related to less adherence, such as not thinking
about the medication because of stress and being busy:
Once in a while you forget [taking your medicines],
in certain situations, when you are not at home. You
don’t think about the possibility you won’t be at
home in advance. (female, 75 years, less adherent)
Routines in taking medication were experienced as factors
related to higher levels of adherence. Many patients had
developed certain habits that were a safeguard to remember
their times of intake. Patients were creative in these drug
plans:
Well, we put the medicines near the breakfast plates,
in sight. So it’s easy to keep in mind In the morning
you open the kitchen cupboard and then you
remember. (male, 67 years, adherent)
Another way to fit medication use in the daily regimen was
to attune times of intake with common patterns. Daily
routines and regularity were related with higher adherence,
also in the next patient who was less adherent when she
deviated from her daily routines:
Well, sometimes I forget the drugs to control my
sugar. When I am somewhere else it happens that I
think: ‘‘Oops, I have forgotten my medicines.’’
…This is what I’m used to do [when I am at home]:
get up, go to the bathroom, and take my medicines.
It’s quite a ritual, honestly. (female, 72 years, less
adherent)
Discussion
We found comparable aspects that were related to adher-
ence in adherent and less adherent patients. Patients iden-
tified four aspects related to adherence to medication: (1)
information about the prescribed medication, (2) experi-
ence with medication and complications with using medi-
cation, (3) social support for medication behaviour and (4)
routines in medication behaviour. Experience with medi-
cation and social support for medication behaviour were
related to high levels of adherence in some patients, and to
lower levels of adherence in others. Complications with
medication usage were related to lower levels of adher-
ence, and both information about medication and routines
were factors related to high levels of adherence.
This study confirms previous findings in the literature.
Information, experience with medication and complica-
tions with use, social support and routines in medication
behaviour have been found in other qualitative and quan-
titative studies as factors influencing drug adherence,
however mostly they were identified separately [1, 5, 16,
17, 27, 28]. In this study, these aspects were identified
together, in both adherent and less adherent patients. This
suggest that these factors are the same for adherent and less
adherent patients, and that patients with good and poor
control of diabetes identify the same types of problems in
managing their disease [29].
In diabetes, barriers to adherence were related to qual-
itative factors as health beliefs, context and relationships
[18]. We found factors as earlier experiences with medi-
cation and social support to be related to both lower and
high adherence. Earlier experiences could be related to less
adherence in some patients, for example when they expe-
rience side effects. Other patients had family members with
severe complications, and these experiences were related to
higher adherence. Because qualitative analysis explores
concepts such as health beliefs in all their complexity, a
relationship described by one patient is different as a
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relationship described by another. This might explain why
for chronic treatment no simple intervention to enhance
adherence to medication was effective [11]. Only some
studies that investigated complex interventions that com-
bined different strategies led to (small) improvements in
adherence [11].
Our study adds to existing literature that adherence is
not only related to the patient’s experience with current
medication, but also to experiences with the disease, with
medication in the past, and experiences of people within
close relationship to the patient. These experiences influ-
ence the patient’s attitude towards diabetes medicines, as
well as the opinion of the treating physician [30].
Lack of routines could hamper drug adherence, but
habitational behaviour was mentioned to favour adherence.
A factor that emerged in this study were routines in drug
behaviour. In studies that investigated drug behaviour of
HIV-positive drug users, structured life and routines were
found important factors related to adherence [31]. A review
of interventions by pharmacists showed that a system of
reminders improved medication adherence [32], and a
recent study demonstrated that routines were important for
drug adherence in elderly [33].
Although the results from our study are too limited to
develop a theoretical framework on its own, we discuss
how our findings might fit within the Common Sense
Model (CSM) [34]. According to the CSM, cognitive and
emotional processes operate independently, and this model
proposes three stages that regulate behaviour: (1) repre-
sentation of the illness (IR), (2) the patient’s coping strat-
egy and (3) the appraisal stage in which coping and
progress are assessed.
We can consider opinions about adherence towards
medication as one of the domains of the IR of diabetes. Our
results show that the patient’s current and past experiences
with the disease, and experiences of people within close
relationship of the patient were related to high or lower
levels of adherence. Within the CSM this can be inter-
preted as coping strategies that can influence the IR of the
patient. In a similar way, social support can be interpreted
as coping strategy by adding information to the patient’s
beliefs. The development of routines can be seen as a
coping strategy how to organise medication behaviour. The
goal of this behaviour is that the potential danger is
regulated.
It has been proven difficult to develop interventions that
improve adherence. [11, 35] Probably, different factors are
relevant for different patients and tailored individualised
strategies are needed [36, 37]. With respect to information
about medication, knowledge, and social support inter-
vention strategies show limited success [11]. Interventions
that were effective were complex, and combining inter-
ventions in drug adherence with other lifestyle
interventions such as diet and physical activity might be
more effective, as patients find undertaking multiple life-
style changes at the same time helpful [38].
Dependent upon the underlying cause for not taking
medication, supporting routines in medication behaviour
might be promising to investigate further when developing
new intervention strategies to improve adherence [39].
Routines do not require conscious deliberation of health
choices, and they may avoid unpleasant thoughts about the
disease. A review of pharmacist’s interventions to enhance
diabetes adherence found five studies that described an
intervention, of which the one that stimulated routines was
the only one that improved adherence clearly [32]. To
increase medication adherence in patients with diabetes
type 2, interventions that stimulate routines in medication
behaviour might be developed.
Obviously, our study has certain limitations. A first
limitation of this study was that a limited number of
patients were interviewed, and these patients participated
in an earlier study about drug use and adherence. We
identified less adherent patients by self report. It is likely
that the type of patients that admit being less adherent
differ from the patients that are less adherent, but report
themselves to be adherent. We divided patients in more and
less adherent according to their MARS-score. The MARS-
questionnaire has not been developed to provide a cut-off
for adherent and less adherent patients, and also the
MARS-score might not agree with real adherence [8].
Moreover, adherence is not a static state of being, and
actual adherence for patients in both groups may have
varied across the study period.
A second limitation was that the presence of family
members influenced the interview. Although this might
also limit the free expression of thought and lead to social
desirable answers, we believe in this setting the contribu-
tion of a spouse led to more detailed information about the
patient’s thoughts and experiences.
Strengths of this study were that the researchers were
not involved in the process of diabetes care themselves. To
reduce interviewer bias two researchers interviewed
patients using the same topic guide.
Conclusion
Information about medication, experience with medication
and complications with using medication, support for
medication behaviour and routines in medication behaviour
were factors related to drug adherence. Routines in medi-
cation behaviour were related to high drug adherence.
Patient education should not only address knowledge about
the disease and medication, but also more practical issues
concerning drug taking. Hence, to improve drug adherence
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in patients with type 2 diabetes, pharmaceutical care might
be aimed at the counselling of patients to organise drug use
in their daily schedule.
Acknowledgments We wish to thank all patients, their family
members and the general practitioners for their contribution to this
study.
Funding None.
Conflicts of interest None declared.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Sabate´ E. Adherence to long-term therapies. In: WHO, editor.
2003. Geneva: WHO.
2. Cramer JA. A systematic review of adherence with medications
for diabetes. Diabetes Care. 2004;27(5):1218–24.
3. Morris LS, Schulz RM. Patient compliance—an overview. J Clin
Pharm Ther. 1992;17(5):283–95.
4. Funnell MM, Anderson RM. MSJAMA: the problem with com-
pliance in diabetes. JAMA. 2000;284(13):1709.
5. Brown JB, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C,
Stewart M. The role of patient, physician and systemic factors in
the management of type 2 diabetes mellitus. Fam Pract.
2002;19(4):344–9.
6. Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S,
et al. Adherence to preventive medications: predictors and out-
comes in the diabetes prevention program. Diabetes Care.
2006;29(9):1997–2002.
7. Pedan A, Varasteh L, Schneeweiss S. Analysis of factors asso-
ciated with statin adherence in a hierarchical model considering
physician, pharmacy, patient, and prescription characteristics.
J Manag Care Pharm. 2007;13(6):487–96.
8. Mardby AC, Akerlind I, Jorgensen T. Beliefs about medicines
and self-reported adherence among pharmacy clients. Patient
Educ Couns. 2007;69(1–3):158–64.
9. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and
medication adherence in patients with type 2 diabetes. Diabetes
Care. 2003;26(5):1408–12.
10. Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lin-
denmeyer A. Interventions for improving adherence to treatment
recommendations in people with type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2005;(2):CD003638.
11. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Inter-
ventions for enhancing medication adherence. Cochrane Data-
base Syst Rev. 2008;(2):CD000011.
12. Nurymberg K, Kreitler S, Weissler K. The cognitive orientation
of compliance in short- and long-term type 2 diabetic patients.
Patient Educ Couns. 1996;29(1):25–39.
13. Rubin RR. Adherence to pharmacologic therapy in patients with
type 2 diabetes mellitus. Am J Med. 2005;118(Suppl 5A):27S–
34S.
14. Morris LS, Schulz RM. Medication compliance: the patient’s
perspective. Clin Ther. 1993;15(3):593–606.
15. Grol R, Wensing M, Mainz J, Ferreira P, Hearnshaw H, Hjortdahl
P, et al. Patients’ priorities with respect to general practice care:
an international comparison. European task force on patient
evaluations of general practice (EUROPEP). Fam Pract.
1999;16(1):4–11.
16. Vinter-Repalust N, Petricek G, Katic M. Obstacles which patients
with type 2 diabetes meet while adhering to the therapeutic
regimen in everyday life: qualitative study. Croat Med J.
2004;45(5):630–6.
17. Vermeire E, Van Royen P, Wens J, Denekens J. The adherence of
type 2 diabetes patients to their therapeutic regimens: a qualita-
tive study from the patient’s perspective. Pract Diabetes Int.
2003;20(6):209–14.
18. Vermeire E, Hearnshaw H, Ratsep A, Levasseur G, Petek D, van
Dam H, et al. Obstacles to adherence in living with type-2 dia-
betes: an international qualitative study using meta-ethnography
(EUROBSTACLE). Prim Care Diabetes. 2007;1(1):25–33.
19. Samadhan A, Meeuse JC, Derraz S, Dusseljee T, Oirbans T,
Borgsteede S, et al. Adherence to different drugs in patients with
type II diabetes (abstract). Br J Clin Pharmacol. 2006;62(6):731.
20. Horne R, Weinman J, Hankins M. The beliefs about medicines
questionnaire: the development and evaluation of a new method
for assessing the cognitive representation of medication. Psychol
Health. 1999;14:1–24.
21. Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler
D, et al. A large-scale validation study of the medication adher-
ence rating scale (MARS). Schizophr Res. 2008;100(1–3):53–9.
22. Mason J. Qualitative researching. 2nd ed. London: Sage Publi-
cations; 2002.
23. Bowskill R, Clatworthy J, Parham R, Rank T, Horne R. Patients’
perceptions of information received about medication prescribed
for bipolar disorder: implications for informed choice. J Affect
Disord. 2007;100(1–3):253–7.
24. George J, Kong DC, Thoman R, Stewart K. Factors associated
with medication nonadherence in patients with COPD. Chest.
2005;128(5):3198–204.
25. WHO Collaborating Centre for Drug Statistics Methodology.
ATC index with DDDs. Oslo: WHO; 2003.
26. Dalgard OS. Social support—Definition and scope. http://www.
euphix.org EUphact\Determinants of health\Environment\Social
support (2009). Cited 4 Jan 2011.
27. Veazie PJ, Cai S. A connection between medication adherence,
patient sense of uniqueness, and the personalization of informa-
tion. Med Hypotheses. 2007;68(2):335–42.
28. Ryan GW, Wagner GJ. Pill taking ‘routinization’: a critical factor
to understanding episodic medication adherence. AIDS Care.
2003;15(6):795–806.
29. Hill-Briggs F, Cooper DC, Loman K, Brancati FL, Cooper LA. A
qualitative study of problem solving and diabetes control in type 2
diabetes self-management. Diabetes Educ. 2003;29(6):1018–28.
30. Anderson RM, Funnell MM. Compliance and adherence are
dysfunctional concepts in diabetes care. Diabetes Educ. 2000;
26(4):597–604.
31. Wagner GJ, Ryan GW. Relationship between routinization of
daily behaviors and medication adherence in HIV-positive drug
users. AIDS Patient Care STDS. 2004;18(7):385–93.
32. Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens
J, Biot Y. Interventions to improve adherence to medication in
people with type 2 diabetes mellitus: a review of the literature on
the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409–19.
33. Tordoff J, Simonsen K, Thomson WM, Norris PT. ‘‘It’s just
routine.’’ A qualitative study of medicine-taking amongst older
people in New Zealand. Pharm World Sci. 2010;32(2):154–61.
34. Harvey JN, Lawson VL. The importance of health belief models
in determining self-care behaviour in diabetes. Diabetic Med.
2009;26(1):5–13.
35. Wens J, Vermeire E, Hearnshaw H, Lindenmeyer A, Biot Y, Van
Royen P. Educational interventions aiming at improving
786 Int J Clin Pharm (2011) 33:779–787
123
adherence to treatment recommendations in type 2 diabetes: a
sub-analysis of a systematic review of randomised controlled
trials. Diabetes Res Clin Pract. 2008;79(3):377–88.
36. Thorne S, Paterson B, Russell C. The structure of everyday self-
care decision making in chronic illness. Qual Health Res.
2003;13(10):1337–52.
37. Velligan DI, Wang M, Diamond P, Glahn DC, Castillo D, Bendle
S, et al. Relationships among subjective and objective measures
of adherence to oral antipsychotic medications. Psychiatr Serv.
2007;58(9):1187–92.
38. Malpass A, Andrews R, Turner KM. Patients with Type 2 Dia-
betes experiences of making multiple lifestyle changes: a quali-
tative study. Patient Educ Couns. 2009;74(2):258–63.
39. Reach G. Role of habit in adherence to medical treatment. Dia-
betic Med. 2005;22(4):415–20.
Int J Clin Pharm (2011) 33:779–787 787
123
